These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Wegovy and semaglutide-based diabetes therapy Ozempic – which grew 12% to DKK 33.85 billion in the fourth quarter – have been the driving force behind Novo Nordisk's sector-beating growth ...

CARTERVILLE, Mo. — A new business means the beginning of a new opportunity for Carterville. Rachel Maddow breaks down new ...

The Vatican announces Saturday that Pope Francis, already hospitalized, was in critical condition following additional health ...